| Title | Protective role of c-Jun N-terminal kinase 2 in acetaminophen-induced liver injury. | | Author(s) | Bourdi M, Korrapati MC, Chakraborty M, Yee SB, Pohl LR | | Institution | Molecular and Cellular Toxicology Section, Laboratory of Molecular Immunology, National Heart, Lung, and Blood Institute, National Institutes of Health, Department of Health and Human Services, Building 10, Room 8N 110, 9000 Rockville Pike, Bethesda, MD 20892-1760, USA. | | Source | Biochem Biophys Res Commun 2008 Jun 26. | | Abstract | Recent studies in mice suggest that stress-activated c-Jun N-terminal protein kinase 2 (JNK2) plays a pathologic role in acetaminophen (APAP)-induced liver injury (AILI), a major cause of acute liver failure (ALF). In contrast, we present evidence that JNK2 can have a protective role against AILI. When male C57Bl/6 wild type (WT) and JNK2(-/-) mice were treated with 300mg APAP/kg, 90% of JNK2(-/-) mice died of ALF compared to 20% of WT mice within 48h. The high susceptibility of JNK2(-/-) mice to AILI appears to be due in part to deficiencies in hepatocyte proliferation and repair. Therefore, our findings are consistent with JNK2 signaling playing a protective role in AILI and further suggest that the use of JNK inhibitors as a potential treatment for AILI, as has been recommended by other investigators, should be reconsidered. | | Language | ENG | | Pub Type(s) | JOURNAL ARTICLE
| | PubMed ID | 18586006 |
|
